Rapid Generation of Monoclonal Antibodies from Single B Cells by Ecobody Technology

Single B cell sampling following to direct gene amplification and transient expression in animal cells has been recognized as powerful monoclonal antibodies (mAbs) screening strategies. Here we report Ecobody technology which allows mAbs screening from single B cells in two days This technology uses...

Full description

Bibliographic Details
Main Authors: Teruyo Ojima-Kato, Shiomi Morishita, Yoshino Uchida, Satomi Nagai, Takaaki Kojima, Hideo Nakano
Format: Article
Language:English
Published: MDPI AG 2018-11-01
Series:Antibodies
Subjects:
Online Access:https://www.mdpi.com/2073-4468/7/4/38
id doaj-b907d0f3f069458bb86100fdd24de2ed
record_format Article
spelling doaj-b907d0f3f069458bb86100fdd24de2ed2020-11-25T00:29:49ZengMDPI AGAntibodies2073-44682018-11-01743810.3390/antib7040038antib7040038Rapid Generation of Monoclonal Antibodies from Single B Cells by Ecobody TechnologyTeruyo Ojima-Kato0Shiomi Morishita1Yoshino Uchida2Satomi Nagai3Takaaki Kojima4Hideo Nakano5iBody Inc., Furo-cho 1, Chikusa-ku, Nagoya 464-0814, JapanGraduate School of Bioagricultural Sciences, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, JapanGraduate School of Bioagricultural Sciences, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, JapaniBody Inc., Furo-cho 1, Chikusa-ku, Nagoya 464-0814, JapanGraduate School of Bioagricultural Sciences, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, JapaniBody Inc., Furo-cho 1, Chikusa-ku, Nagoya 464-0814, JapanSingle B cell sampling following to direct gene amplification and transient expression in animal cells has been recognized as powerful monoclonal antibodies (mAbs) screening strategies. Here we report Ecobody technology which allows mAbs screening from single B cells in two days This technology uses <i>Escherichia coli</i> cell-free protein synthesis (CFPS) for mAb expression. In the CFPS step, we employed our original techniques: (1) &#8216;Zipbody&#8217; as a modified Fab (fragment of antigen binding) format, in which the active Fab formation is facilitated by adhesive leucine zipper peptides fused at the C-termini of the light and heavy chains; and (2) an N-terminal SKIK peptide tag that can markedly increase protein production. By the Ecobody technology, we demonstrated rapid screening of antigen specific mAbs from immunized rabbits and Epstein-Barr Virus infected human B cells. We further obtained rabbit mAbs in <i>E. coli</i> expression system yielding to 8.5 mg of purified proteins from 1 L bacterial culture.https://www.mdpi.com/2073-4468/7/4/38single B cell technologyrabbit antibodieshuman antibodies
collection DOAJ
language English
format Article
sources DOAJ
author Teruyo Ojima-Kato
Shiomi Morishita
Yoshino Uchida
Satomi Nagai
Takaaki Kojima
Hideo Nakano
spellingShingle Teruyo Ojima-Kato
Shiomi Morishita
Yoshino Uchida
Satomi Nagai
Takaaki Kojima
Hideo Nakano
Rapid Generation of Monoclonal Antibodies from Single B Cells by Ecobody Technology
Antibodies
single B cell technology
rabbit antibodies
human antibodies
author_facet Teruyo Ojima-Kato
Shiomi Morishita
Yoshino Uchida
Satomi Nagai
Takaaki Kojima
Hideo Nakano
author_sort Teruyo Ojima-Kato
title Rapid Generation of Monoclonal Antibodies from Single B Cells by Ecobody Technology
title_short Rapid Generation of Monoclonal Antibodies from Single B Cells by Ecobody Technology
title_full Rapid Generation of Monoclonal Antibodies from Single B Cells by Ecobody Technology
title_fullStr Rapid Generation of Monoclonal Antibodies from Single B Cells by Ecobody Technology
title_full_unstemmed Rapid Generation of Monoclonal Antibodies from Single B Cells by Ecobody Technology
title_sort rapid generation of monoclonal antibodies from single b cells by ecobody technology
publisher MDPI AG
series Antibodies
issn 2073-4468
publishDate 2018-11-01
description Single B cell sampling following to direct gene amplification and transient expression in animal cells has been recognized as powerful monoclonal antibodies (mAbs) screening strategies. Here we report Ecobody technology which allows mAbs screening from single B cells in two days This technology uses <i>Escherichia coli</i> cell-free protein synthesis (CFPS) for mAb expression. In the CFPS step, we employed our original techniques: (1) &#8216;Zipbody&#8217; as a modified Fab (fragment of antigen binding) format, in which the active Fab formation is facilitated by adhesive leucine zipper peptides fused at the C-termini of the light and heavy chains; and (2) an N-terminal SKIK peptide tag that can markedly increase protein production. By the Ecobody technology, we demonstrated rapid screening of antigen specific mAbs from immunized rabbits and Epstein-Barr Virus infected human B cells. We further obtained rabbit mAbs in <i>E. coli</i> expression system yielding to 8.5 mg of purified proteins from 1 L bacterial culture.
topic single B cell technology
rabbit antibodies
human antibodies
url https://www.mdpi.com/2073-4468/7/4/38
work_keys_str_mv AT teruyoojimakato rapidgenerationofmonoclonalantibodiesfromsinglebcellsbyecobodytechnology
AT shiomimorishita rapidgenerationofmonoclonalantibodiesfromsinglebcellsbyecobodytechnology
AT yoshinouchida rapidgenerationofmonoclonalantibodiesfromsinglebcellsbyecobodytechnology
AT satominagai rapidgenerationofmonoclonalantibodiesfromsinglebcellsbyecobodytechnology
AT takaakikojima rapidgenerationofmonoclonalantibodiesfromsinglebcellsbyecobodytechnology
AT hideonakano rapidgenerationofmonoclonalantibodiesfromsinglebcellsbyecobodytechnology
_version_ 1725329744482795520